… /o/w) is applied for water-soluble drugs ( Figure 4B ). First, the aqueous solution of the drug is
… in an organic solvent (oil phase) containing polymer and lipid to form aw/o mixture. A w/o/w …

… for long circulation of siRNA wherein the aqueous solution of siRNA and acetone with G0-…
“differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles” comprised of …

… solution, it is heated up to 60-70C. Polymer solution is then added dropwise to the
aqueous solution … The system is referred as Differentially charged hollow core/shell lipidpolymer-lipid …

… phase (aqueous medium of the lipid vesicles and polymer NPs); and (iv) lipid vesicle-to-polymeric
NP ratio, as reported elsewhere [97]. Anionic polystyrene NPs are used as the core …

… , important factors such as line tension at lipid polymer/lipid boundaries can be finely modulated
by the … We had exactly the same phase behaviour described above for DOW, 1.5K or 3K …

… In the single-step method, the drug and polymer solution in a water-miscible organic
solvent is added to an aqueous medium encompassing lipids or lipid–PEG, with spontaneous …

… After this, nanoparticle were removed from the mold and with the help of aqueous solution
of lipids nanoparticles were separated from PVA coated PET sheets leading to the formation …

… If the drug is soluble in oil phase (water-immiscible organic solvent), then single-phase
emulsion is implied [110]. Double/multiple-emulsion method is used when the substance to be …

… solution is created when the lipid from the aqueous medium dissolves and is added to the
solution. The … The core–shell lipid-polymer–lipid systems (CSLPL) system consists of a hollow …

… shift in the phase transition temperature of lipidoid, and the thermotropic phase behavior of
… likely to adopt a lamellar phase upon dispersion in aqueous medium, which is in accordance …